← Back to Clinical Trials
Recruiting NCT06728527

NCT06728527 PARTial BREast RECONstruction With Chest Wall Perforator Flap

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06728527
Status Recruiting
Phase
Sponsor Cambridge University Hospitals NHS Foundation Trust
Condition Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Study Type OBSERVATIONAL
Enrollment 1,001 participants
Start Date 2023-06-01
Primary Completion 2026-05-31

Trial Parameters

Condition Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Sponsor Cambridge University Hospitals NHS Foundation Trust
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,001
Sex FEMALE
Min Age 18 Years
Max Age N/A
Start Date 2023-06-01
Completion 2026-05-31

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to ascertain the outcomes following partial breast reconstruction using chest wall perforator flaps after breast conservation surgery.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing partial breast reconstruction using CWPF for primary breast cancer * Delayed correction of breast deformity following previous BCS * Each surgeon is to have performed a minimum of 10 CWPFs * Each centre anticipates completing a minimum of 10/year Exclusion Criteria: * Patients undergoing volume displacement BCS * Patients undergoing mastectomy +/- immediate breast reconstruction

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology